2755197-77-2
2755197-77-2
Chemical Structure
Rapirosiran sodium
Synonym(s): ALN-HSD sodium
- CAS No.: 2755197-77-2
- Formula:N/A
- Molecular Weight:16307.22 (free acid)
SMILES: [Rapirosiran (sodium)]
Biological Activity: Rapirosiran (ALN-HSD) sodium is a HSD17β13-targeting siRNA. Rapirosiran sodium can be used for the research of metabolic dysfunction-associated steatohepatitis[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rapirosiran sodium | 97.39% | Rapirosiran (ALN-HSD) sodium is a HSD17β13-targeting siRNA. Rapirosiran sodium can be used for the research of metabolic dysfunction-associated steatohepatitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Sanyal AJ, et al. Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis. J Hepatol. 2025;83(4):838-848. [Content Brief]
- [2]. Yu JJ, et al. New Research Progress of Small Interfering RNA Drugs in the Field of Chronic Diseases: from Preclinical to Clinical. Prog. Pharm. Sci. 2024 Mar 14;48(8):579-591.
Keywords
